New horizons for stroke prevention: PROGRESS and HOPE
- 1 July 2002
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 1 (3), 149-156
- https://doi.org/10.1016/s1474-4422(02)00070-4
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Comparative Effects of Ramipril on Ambulatory and Office Blood PressuresHypertension, 2001
- Race-Ethnic Disparities in the Impact of Stroke Risk FactorsStroke, 2001
- Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive PatientsHypertension, 1999
- Effect of Antihypertensive Treatment in Patients Having Already Suffered From StrokeStroke, 1997
- Formulary Management of ACE InhibitorsPharmacoEconomics, 1996
- Effects of Angiotensin-Converting Enzyme Inhibitors on the Heart and Vessels in Clinical and Experimental HypertensionClinical Drug Investigation, 1996
- Atherosclerosis: Risk factors and the vascular endotheliumAmerican Heart Journal, 1996
- Hypertensive Cerebrovascular Disease and the Renin-Angiotensin SystemStroke, 1995
- Effect of Antihypertensive Treatment on Small Arteries of Patients With Previously Untreated Essential HypertensionHypertension, 1995
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990